Literature DB >> 18240341

Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.

Gert De Hertogh1, Jeroen Aerssens, Karen P Geboes, Karel Geboes.   

Abstract

Many advances have been made in the understanding of Crohn's disease (CD) pathogenesis during the last decade. CD is currently seen as a predominantly T-lymphocyte-driven disease characterized by the presence of a complex cocktail of interacting cytokines, chemokines and other mediators produced by a variety of cell types. Prevailing theories of CD pathogenesis suggest that patients' T-lymphocytes are inappropriately activated in the setting of an immune imbalance, which is itself caused by an unfortunate confluence of genetic and environmental factors. The T-cell response then leads to the chronic inflammation characteristic for the disease. Various environmental factors may play a role in the development of CD, but microbes are most consistently implied. This theory is based on epidemiological, clinicopathological, genetic and experimental evidence. Despite the abundance of arguments for the implication of bacteria in the aetiopathogenesis of CD, the precise role of bacteria in this disease still remains elusive. Three not necessarily mutually exclusive theories have been proposed: (1) an unidentified persistent pathogen; (2) an abnormally permeable mucosal barrier leading to excessive bacterial translocation; and (3) a breakdown in the balance between putative "protective" versus "harmful" intestinal bacteria ("dysbiosis"). At present, one cannot exclude with certainty any of these three proposed hypotheses; they may all apply to CD to a certain extent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18240341      PMCID: PMC2687051          DOI: 10.3748/wjg.14.845

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  125 in total

1.  Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum.

Authors:  P Rutgeerts; K Goboes; M Peeters; M Hiele; F Penninckx; R Aerts; R Kerremans; G Vantrappen
Journal:  Lancet       Date:  1991-09-28       Impact factor: 79.321

2.  Double blind, placebo controlled trial of metronidazole in Crohn's disease.

Authors:  L Sutherland; J Singleton; J Sessions; S Hanauer; E Krawitt; G Rankin; R Summers; H Mekhjian; N Greenberger; M Kelly
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls.

Authors:  C Schultsz; F M Van Den Berg; F W Ten Kate; G N Tytgat; J Dankert
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

4.  Breast-feeding and maternal smoking in the etiology of Crohn's disease and ulcerative colitis in childhood.

Authors:  A Rigas; B Rigas; M Glassman; Y Y Yen; S J Lan; E Petridou; C C Hsieh; D Trichopoulos
Journal:  Ann Epidemiol       Date:  1993-07       Impact factor: 3.797

5.  Open label trial of oral clarithromycin in active Crohn's disease.

Authors:  K Leiper; A I Morris; J M Rhodes
Journal:  Aliment Pharmacol Ther       Date:  2000-06       Impact factor: 8.171

6.  Nipple valve anastomosis for preventing recurrence of Crohn disease in the neoterminal ileum after ileocolic resection. A prospective pilot study.

Authors:  K E Bakkevold
Journal:  Scand J Gastroenterol       Date:  2000-03       Impact factor: 2.423

Review 7.  [Bacterial translocation in Crohn disease].

Authors:  G Laffineur; D Lescut; P Vincent; P Quandalle; A Wurtz; J F Colombel
Journal:  Gastroenterol Clin Biol       Date:  1992

8.  The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique.

Authors:  M H Giaffer; C D Holdsworth; B I Duerden
Journal:  J Med Microbiol       Date:  1991-10       Impact factor: 2.472

9.  Mycobacterium paratuberculosis and Crohn's disease.

Authors:  K Tanaka; M Wilks; P J Coates; M J Farthing; J A Walker-Smith; S Tabaqchali
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

10.  Chlamydia trachomatis and inflammatory bowel disease--a coincidence?

Authors:  R Orda; Z Samra; Y Levy; Y Shperber; E Scapa
Journal:  J R Soc Med       Date:  1990-01       Impact factor: 18.000

View more
  28 in total

Review 1.  Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: a systematic review and meta-analysis.

Authors:  Amit Kaul; Susan Hutfless; Ling Liu; Theodore M Bayless; Michael R Marohn; Xuhang Li
Journal:  Inflamm Bowel Dis       Date:  2012-01-31       Impact factor: 5.325

2.  Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study.

Authors:  Laura R Glick; Philip H Sossenheimer; Jacob E Ollech; Russell D Cohen; Neil H Hyman; Roger D Hurst; David T Rubin
Journal:  J Crohns Colitis       Date:  2019-09-19       Impact factor: 9.071

3.  Role of Salmonella enterica exposure in Chilean Crohn's disease patients.

Authors:  Manuel Alvarez-Lobos; Daniela P Pizarro; Christian E Palavecino; Abner Espinoza; Valentina P Sebastián; Juan C Alvarado; Patricio Ibañez; Carlos Quintana; Orlando Díaz; Alexis M Kalergis; Susan M Bueno
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 4.  Use of antibiotics in the treatment of Crohn's disease.

Authors:  Maria Lia Scribano; Cosimo Prantera
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

5.  Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease.

Authors:  Nair Nazareth; Fernando Magro; Elisabete Machado; Teresa Gonçalves Ribeiro; António Martinho; Pedro Rodrigues; Rita Alves; Gonçalo Nuno Macedo; Daniela Gracio; Rosa Coelho; Candida Abreu; Rui Appelberg; Camila Dias; Guilherme Macedo; Tim Bull; Amélia Sarmento
Journal:  Med Microbiol Immunol       Date:  2015-05-21       Impact factor: 3.402

6.  Delineating the signals by which repetitive deformation stimulates intestinal epithelial migration across fibronectin.

Authors:  Christopher P Gayer; Lakshmi S Chaturvedi; Shouye Wang; Brittany Alston; Thomas L Flanigan; Marc D Basson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

7.  Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease.

Authors:  Abhik Roy; Simon Lichtiger
Journal:  Inflamm Bowel Dis       Date:  2016-03       Impact factor: 5.325

Review 8.  Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease?

Authors:  Ellen S Pierce
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

9.  Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC).

Authors:  Margarita Martinez-Medina; Plínio Naves; Jorge Blanco; Xavier Aldeguer; Jesus E Blanco; Miguel Blanco; Carmen Ponte; Francisco Soriano; Arlette Darfeuille-Michaud; L Jesus Garcia-Gil
Journal:  BMC Microbiol       Date:  2009-09-21       Impact factor: 3.605

10.  Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue.

Authors:  Lucia Marquéz; Juan Suárez; Mar Iglesias; Francisco Javier Bermudez-Silva; Fernando Rodríguez de Fonseca; Montserrat Andreu
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.